Work entails supporting the development of global market access (pricing and reimbursement) strategies for innovative molecules. Experience of working on projects below: - PDP, Core value prospectus (CVP) for early asset development in Virology therapy area - Pricing strategies for early molecules through analogue analysis -Developing competitive landscape, disease overview, epidemiology, pricing and reimbursement scenario to inform the potential BD&L opportunities for Client early development portfolio - Targeted literature reviews (TLR) to answer specific research questions, mainly focusing on HTA, RWE, quality of life data, PROs acceptance by HTA- Worked with Global Patient Access Head to provide inputs on various projects - Patient reported outcomes measure development to conduct patient preference study in COPD and other therapy areas) and their acceptance by HTA agencies - Patient preference studies and their methodology at different stages of development - Stakeholder profiling analysis including medical experts, payers , medical guidelines, academic institutions for various products - Social media listening project for Client early asset. - Using the top-tier sources like APM Health Europe, IMS Pharma Query, IHS Global Insights, Fierce Pharma, Fingertip formulary, Evaluate pharma - Expertise in pricing databases and tools (IMS Pricing Insights, Analy Source)